INVEX Therapeutics Ltd (IXC) — Defensive Interval Ratio

Latest as of June 2026: 6058 days

INVEX Therapeutics Ltd (IXC) has a Defensive Interval Ratio of 6058 days as of June 2026. Defensive assets of AU$2.55 Million (cash AU$-, short-term investments AU$2.50 Million, receivables AU$47.33K) cover 6058 days of daily cash needs of AU$420.47/day.

Defensive Interval Ratio

6058 days
Days of operational coverage

Defensive Assets

AU$2.55 Million
Cash + ST Investments + Receivables

Daily Cash Need

AU$420.47
Current Liabilities ÷ 365

Current Liabilities

AU$153.47K
AUD

INVEX Therapeutics Ltd Defensive Interval Ratio (2019–2026)

This chart shows how INVEX Therapeutics Ltd's Defensive Interval Ratio has evolved across 8 annual periods from 2019 to 2026. As of June 2026, the ratio stands at 6058 days, meaning defensive assets of AU$2.55 Million can fund 6058 days of operations without new revenue. For the complete balance sheet picture, see INVEX Therapeutics Ltd asset portfolio.

Annual Defensive Interval Ratio for INVEX Therapeutics Ltd (2019–2026)

The table below presents the year-by-year Defensive Interval Ratio for INVEX Therapeutics Ltd from 2019 to 2026, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See INVEX Therapeutics Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (AUD) Daily Cash Need Cash ST Investments Change (days)
2026 6058 days AU$2.55 Million AU$420.47/day AU$- AU$2.50 Million ▲ +5905 days
2025 154 days AU$92.79K AU$604.37/day AU$- AU$- ▲ +73 days
2024 80 days AU$94.98K AU$1.18K/day AU$- AU$- ▲ +3 days
2023 77 days AU$333.56K AU$4.31K/day AU$- AU$- ▲ +24 days
2022 53 days AU$145.72K AU$2.75K/day AU$- AU$- ▲ +41 days
2021 12 days AU$21.20K AU$1.80K/day AU$- AU$- ▼ -9 days
2020 21 days AU$116.88K AU$5.52K/day AU$- AU$- ▼ -12 days
2019 33 days AU$85.62K AU$2.56K/day AU$- AU$-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)